Device developers get creative to connect with physicians

Dr. Farzad Azimpour is SVP of Advanced Technology at Edwards Lifesciences [Photo courtesy of Edwards Lifesciences]

Medical device developers have gotten creative in connecting with surgeons and interventionalists during the pandemic.

Leaders from Abbott, Boston Scientific and Edwards Lifesciences shared some of their experiences, challenges and opportunities with attendees of DeviceTalks West in October.

The chief challenge is the number of physicians, nurses and other medical professionals who have left the field during the pandemic.

“The elephant in the room is that everybody is worried about how we’re going to get things to patients,” said Farzad Azimpour, SVP of Advanced Technology at Edwards Lifesciences. “How do we equip the limited capacity that we have right now — from nursing, physicians, everyone — to enable what we have to actually reach patients in a timely and appropriate manner…

Read more
  • 0

How Johnson & Johnson is looking to lead the way in ablation

“If you want to go fast, go alone. If you want to go forward, go together,” Johnson & Johnson’s Celine Martin (left) said of innovation during a DeviceTalks West 2022 keynote interview with MassDevice executive editor Chris Newmarker (right). [Image by Kara Singleton, WTWH Media]Celine Martin, Johnson & Johnson group chair, cardiovascular & specialty solutions (CSS) group, oversees high-growth areas at the company’s global MedTech business.

Her leadership covers Acclarent, Biosense Webster, Cerenovus and Mentor. Together, those companies bring in more than $5 billion in annual sales with more than 14,000 employees.

Over 25 years at Johnson & Johnson, Martin has looked to improve standards of care for AFib, stroke and minimally invasive surgery. At DeviceTalks West in Santa Clara last week, she spoke in a keynote address about how she’s done it.

On treating AFib at Biosense Webster

Martin said at DeviceTalks that…

Read more
  • 0

Medtronic unveils new neurovascular innovation incubator program

Dan Volz (right) and Derek Crittenden (left) present the Medtronic Co-Lab program at DeviceTalks West in Santa Clara, California.

Medtronic (NYSE:MDT) revealed its plans for an incubation and acceleration platform for innovation in the neurovascular space.

In a presentation yesterday at DeviceTalks West in Santa Clara, California, the company unveiled its plan to bring innovations to market to address strokes. Daniel Volz, president of Medtronic Neurovascular, and Derek Crittenden, Medtronic’s new technology & strategy program manager, presented the news.

“We’re pleased to share with you today the Medtronic neurovascular Co-Lab platform,” Volz said. “This is a community platform designed to transform ideas and technologies into novel global therapies by providing physicians and entrepreneurs with insight with support, and most importantly, making sure innovation has the chance to touch as many people around the world as possibl…

Read more
  • 0

How medical device companies can better protect themselves from lawsuits

Getting hit with lawsuits isn’t an if, but a when for medical device developers and manufacturers. A veteran Greenberg Traurig lawyer shares advice for staying secure.

[Image from Pixabay]

As with pharmaceutical companies and health providers, medtech is emerging from the COVID-19 pandemic with a great deal of goodwill, says Ginger Pigott, a Greenberg Traurig shareholder. Pigott has seen the industry’s improved image helping device companies with juries, mock juries and the litigation process in general.

But don’t bet on the trend lasting.

“I’ve been practicing for 30 years, and it goes in that cycle all the time,” Pigott said in a recent interview with Medical Design & Outsourcing. (Pigott will moderate a panel about building startups to last at DeviceTalks West, Oct. 19-20, 2022 in Santa Clara, California.)

In fact, Pigott suspects the present economic unc…

Read more
  • 0

September 2022 Issue: The Medtech Big 100 is bigger than ever

Medtech sales reach a record high as R&D spend and employee counts climb

Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future

Autotransfusion device maker ships units to Ukraine

How IP protection is enabling robotic surgery innovation

Connected device design for the real world: Managing the development process

FDA details plans to expand remote safety assessments for device makers

Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye

The Medtech Big 100 is bigger than ever

The tide has turned.

The Medtech Big 100 — Medical Design & Outsourcing‘s annual revenue ranking of the world’s …

Read more
  • 0

Join us at DeviceTalks West, the World’s Fair of Medtech

Intuitive Surgical CEO Gary Guthart will participate in a keynote interview at DeviceTalks West 2022. [Photo courtesy of Intuitive Surgical]

October’s DeviceTalks West conference is focused on the future.

The best-seller “Devil in the White City” may have darkened the perception of world’s fairs, but these international convocations have long presented visitors with an optimistic and hopeful view of the future, thanks in no small part to new technology. (The next one is scheduled for 2025 in Osaka, Japan, by the way.)

I like to think we’ll be following similar guidelines at the upcoming DeviceTalks West conference, which will be held on Oct. 19-20 at the Santa Clara Convention Center.

This event will bring together executives from Abbott, Boston Scientific, Edwards Lifesciences, Intuitive, Johnson & Johnson, Medtronic, Outset Medical, Penumbra, Shockwave, Zimmer Biomet and many …

Read more
  • 0

Medtronic’s Design for Reliability and Manufacturability after the reorganization

Mike Hess is VP of corporate technology and innovation at Medtronic. [Photo courtesy of Medtronic]

“Play small and play big” was one of CEO Geoff Martha’s mantras as he and his team reorganized Medtronic (NYSE:MDT), the biggest corporation in medtech.

The multi-year effort decentralized Medtronic’s three big groups — cardiology, neuroscience and medical surgical — into 20 narrowly focused operating units (OUs).

“The OUs can maintain focus and accountability, execute faster and make quicker decisions, while retaining the advantages of size and scale. … Play small and play big,” Martha said in an October 2020 communique.

Fast forward to today. Mike Hess, VP of corporate technology and innovation, calls Medtronic’s Design for Reliability and Manufacturability (DRM) program a “great example of the play big, play small mindset.”

“The DRM team…

Read more
  • 0

July 2022 Issue: Pulsed-field ablation, DeviceTalks Boston and the Pharma 50

 

What is pulsed-field ablation? Here’s what you need to know

Dexcom CEO expects ‘science boom’ with CGM, automated insulin delivery

Tips for vetting contract manufacturers

They said it at DeviceTalks Boston

FDA can’t explain drop in device recalls, but experts point to COVID disruption

2022 Pharma 50: The 50 largest pharmaceutical companies

Innovators shake up the Pharma 50

As a father raising a toddler and an infant, I was relieved by the latest milestone in the COVID-19 pandemic: the authorization of vaccines for children between 6 months and 5 years.

The good news came as Pharma Editor Brian Buntz and the rest of our team were putting the final touches on this edition’s Pharma 50 project. It’s our annual ranking of the biggest pharmaceutical companies by global revenue, featured on our affiliated Drug Discovery & Development site. (Our Big 100 report on largest medic…

Read more
  • 0

How Boston Scientific uses clinical feedback to advance innovation

Put simply, the reason most people enter the medtech space is to make a big difference in the lives of patients.

However, the process isn’t always straightforward,

That’s according to Boston Scientific (NYSE:BSX) SVP of Urology and Pelvic Health Meghan Scanlon. Speaking on the “How Boston Scientific uses clinical feedback to advance innovation” panel at DeviceTalks Boston last week, Scanlon explained how vital the early stages of product development can be.

“Early on, have a strong hypothesis for what your value proposition is going to be,” Scanlon said. “But, don’t go etch it in stone tablets. Use a pencil or an erasable marker and constantly test and validate it. Have an understanding of what your evidence generation plan is going to be over time and don’t let the pursuit of perfection be the enemy of progress.”

Scanlon was joined by Boston Scientific VP of Corporate Digital and Patient & Referrer Marketin…

Read more
  • 0

DeviceTalks Boston hosting MedTech Innovator mid-stage pitch competitions on May 10-11

BOSTON – Twenty-six mid-stage medical device startups will pitch their exciting medtech stories at DeviceTalks Boston on May 10-11 at the Boston Convention & Exhibition Center as part of the MedTech Innovator Mid-Stage Companies Pitch Event. 

The pitch event is thanks to a new partnership between DeviceTalks, organizer of a portfolio of events and podcasts serving the medical device community, and MedTech Innovator, the world’s largest medical technology accelerator. 

“We’re proud to host MedTech Innovator at DeviceTalks Boston,” says Tom Salemi, editorial director of DeviceTalks. “Paul Grand and his team do more than help medical device companies tell their stories. They provide a best-in-class global network of corporate partners, advisors and investors that build strong new device and healthtech companies.”  

DeviceTalks Boston attendees will be invited to watch the presentations as part of the event’s “Innovation & Investment” track on …

Read more
  • 0

DeviceTalks Boston hosting MedTech Innovator mid-stage pitch competitions on May 10-11

BOSTON – Twenty-six mid-stage medical device startups will pitch their exciting medtech stories at DeviceTalks Boston on May 10-11 at the Boston Convention & Exhibition Center as part of the MedTech Innovator Mid-Stage Companies Pitch Event. 

The pitch event is thanks to a new partnership between DeviceTalks, organizer of a portfolio of events and podcasts serving the medical device community, and MedTech Innovator, the world’s largest medical technology accelerator. 

“We’re proud to host MedTech Innovator at DeviceTalks Boston,” says Tom Salemi, editorial director of DeviceTalks. “Paul Grand and his team do more than help medical device companies tell their stories. They provide a best-in-class global network of corporate partners, advisors and investors that build strong new device and healthtech companies.”  

DeviceTalks Boston attendees will be invited to watch the presentations as part of the event’s “Innovation & Investment” track on …

Read more
  • 0

DeviceTalks Boston returns with a unique approach for medtech connections and development

DeviceTalks Boston speakers include Meghan Scanlon, senior vice president at Boston Scientific and president of its urology and pelvic health business. [Photo courtesy of Boston Scientific]A few months back, I wrote what was best described by a colleague as a “salty” Medical Design & Outsourcing column in which I demanded conference organizers like myself step up our game if we expect to bring back attendees.

“For too long, conference organizers have relied upon a potent cocktail of FOMO and habit,” I wrote in one particularly briny portion. “Sure, organizers try to amp up content, introduce cool partnering apps and a few gimmicks. (One recent healthcare meeting had puppies, actual puppies … gimmicky, but intriguing.)”

Here I am, four months later, and I still agree with me!

We’ve been working harder — and smarter — to assemble the agenda of DeviceTalks Boston, coming up May 10–11 at the Boston Convention and Exhibition Center. And while I can’t deliver…

Read more
  • 0